Chu‐Biao Xue

1.8k citations
52 papers · 1.0k indexed · h-index 22
Topics
Chemical Synthesis and Analysis (15 papers)Cytokine Signaling Pathways and Interactions (8 papers)Protease and Inhibitor Mechanisms (7 papers)

In The Last Decade

Chu‐Biao Xue

51 papers receiving 974 citations

Peers

Chu‐Biao Xue
Comparison fields: 5 of 83
  • Molecular Biology 577
  • Organic Chemistry 320
  • Oncology 197
  • Cancer Research 108
  • Immunology and Allergy 94
Replace John Porter with:
John Porter United Kingdom
James J.‐W. Duan United States
K. Ulrich Wendt Germany
Robert J. Cherney United States
Guixian Jin United States
Laurie Churchill United States
Jakob Fuhrmann United States
John R. Regan United States
Tianbao Lu United States
Benjamin R. Bowen United States
Chu‐Biao Xue relative to John Porter United Kingdom John Porter's profile →
Citations per field
00.5×1.5×
John Porter · 1×
Citations per year

Countries citing papers authored by Chu‐Biao Xue

Since Specialization
Citations

This map shows the geographic impact of Chu‐Biao Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chu‐Biao Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chu‐Biao Xue more than expected).

Fields of papers citing papers by Chu‐Biao Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chu‐Biao Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chu‐Biao Xue. The network helps show where Chu‐Biao Xue may publish in the future.

Co-authorship network of co-authors of Chu‐Biao Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Chu‐Biao Xue. A scholar is included among the top collaborators of Chu‐Biao Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chu‐Biao Xue. Chu‐Biao Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 21
3 37
4 13
5 27
6 21
7 38
8 26
9 47
10 28
11 13
12 6
13 41
14 12
15 7
16 11
17 18
18 5
19 7
20 28

About Chu‐Biao Xue

Chu‐Biao Xue is a scholar working on Immunology and Allergy, Organic Chemistry and Hematology, having authored 52 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (15 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Protease and Inhibitor Mechanisms (7 papers). The work is most often cited by research in Immunology and Allergy (94 citations), Organic Chemistry (320 citations) and Molecular Biology (577 citations). Chu‐Biao Xue has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Fred Naider, Yufen Zhao, Jeffrey M. Becker, Carl P. Decicco, John Roderick, William F. DeGrado, Yingwu Yin, James J.‐W. Duan, Jianing Zeng and Rui‐Qin Liu. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026